Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/115813
Title: Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience
Authors: Vaarwerk, Bas
Mallebranche, Coralie
Affinita, Maria C
van der Lee, Johanna H
Ferrari, Andrea
Chisholm, Julia C
Defachelles, Anne-Sophie
De Salvo, Gian Luca 
Corradini, Nadège
Minard-Colin, Veronique
Morosi, Carlo
Brisse, Hervé J
McHugh, Kieran
Bisogno, Gianni 
van Rijn, Rick R
Orbach, Daniel
Merks, Johannes H M
Keywords: radiology;rhabdomyosarcoma;surveillance imaging;survival
Keywords Plus: SOFT-TISSUE SARCOMAS;FOLLOW-UP;CT SCANS;RECURRENCE;CHILDHOOD;SURVIVAL;ONCOLOGY;RELAPSE;RISK;ANESTHESIA
Issue Date: 15-Feb-2020
Publisher: WILEY
Journal: Cancer 
Abstract: 
After the completion of therapy, patients with localized rhabdomyosarcoma (RMS) are subjected to intensive radiological tumor surveillance. However, the clinical benefit of this surveillance is unclear. This study retrospectively analyzed the value of off-therapy surveillance by comparing the survival of patients in whom relapse was detected by routine imaging (the imaging group) and patients in whom relapse was first suspected by symptoms (the symptom group).
URI: http://hdl.handle.net/20.500.12857/115813
ISSN: 0008543X
DOI: 10.1002/cncr.32603
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

4
Last Week
3
Last month
checked on May 2, 2021

SCOPUSTM   
Citations

2
checked on Sep 1, 2020

WEB OF SCIENCETM
Citations

7
checked on Dec 4, 2021

Page view(s) 5

2
checked on Dec 6, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.